Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Lymphoid 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Carcinoma, Hepatocellular 25Carcinoma, Non-Small-Cell Lung 14Squamous Cell Carcinoma of Head and Neck 11Melanoma 10Breast Neoplasms 10Urinary Bladder Neoplasms 9Colorectal Neoplasms 9Lung Neoplasms 6Cholangiocarcinoma 6Carcinoma, Renal Cell 6Biliary Tract Neoplasms 6Adenocarcinoma Of Esophagus 6Ovarian Neoplasms 5Liver Neoplasms 5Diabetes Mellitus, Insulin-Dependent, 12 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Mesothelioma, Malignant 4Head and Neck Neoplasms 4Neoplasm Metastasis 3Mesothelioma 3Kidney Neoplasms 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Vulvar Neoplasms 2Vaginal Neoplasms 2

Interventions

Etoposide 19Carboplatin 19Ifosfamide 16Filgrastim 16Peripheral Blood Stem Cell Transplantation 13Paclitaxel 13Cisplatin 12Cyclophosphamide 10Thiotepa 7Therapeutics 5Radiotherapy 5Melphalan 5Busulfan 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Flow Cytometry 4pegfilgrastim 3etoposide phosphate 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Methylprednisolone 3Methods 3Immunologic Techniques 3Granulocyte Colony-Stimulating Factor 3Epirubicin 3Dexamethasone 3Blood Specimen Collection 3Bleomycin 3tremelimumab 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Testicular Neoplasms × tremelimumab × Clear all
NCT02643303 2022-12-02

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Ludwig Institute for Cancer Research

Phase 1/2 Completed
58 enrolled 24 charts
BreastDermatologicGenitourinaryHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Kidney Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Lymphoma, T-Cell, Cutaneous

NCT03081923 2021-05-14

APACHE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Terminated
36 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡